Results 191 to 200 of about 15,597 (227)

Sixty seconds on . . . psilocybin

BMJ, 2016
Not so fast. There’s a long way to go. But a study in London has shown that the active ingredient in magic mushrooms, psilocybin, may be effective against treatment resistant depression. Its effects were quick—within a week—and more than 40% of the patients treated were still in remission three months later.1 Yes, as far as it goes.
openaire   +2 more sources

Trial of Psilocybin versus Escitalopram for Depression

New England Journal of Medicine, 2021
Robin Carhart-Harris, David Erritzøe
exaly  

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

New England Journal of Medicine, 2022
Scott T Aaronson, Catherine I V Bird, Robin Carhart-Harris   +2 more
exaly  

Increased global integration in the brain after psilocybin therapy for depression

Nature Medicine, 2022
Richard E Daws, Christopher Timmermann, James D Sexton   +2 more
exaly  

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

Journal of Psychopharmacology, 2022
Natalie Gukasyan, Alan K Davis, Frederick S Barrett   +2 more
exaly  

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

EClinicalMedicine, 2023
Robin von Rotz, Eva Maria Schindowski, Erich Seifritz   +2 more
exaly  

Psilocybin

2016
openaire   +2 more sources

Psilocybin

Journal of Psychedelic Drugs, 1980
openaire   +1 more source

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer

Journal of Psychopharmacology, 2020
Gabrielle I Agin-Liebes, Stephen Ross
exaly  

Psilocybin

2020
openaire   +1 more source